Role

The CAC:

  • reviews and advises of clinical evidence regarding the BreastScreen Australia program
  • advises on national clinical policies and procedures, and new and emerging technologies
  • advises about clinical issues and risks.

Advice is provided within the context of current evidence-based best practice, and aligned with relevant college policies, guidelines and legislation.

The aim is to improve the delivery of breast screening services that are:

  • nationally consistent
  • evidence based
  • high quality.

Members

Clinical Advisory Committee members include:

  • 2 radiologists, with experience in breast screening
  • a breast physician
  • a breast surgeon
  • 2 pathologists, with experience in breast screening
  • a radiographer, with experience in breast screening
  • a program management representative
  • an Australian Government representative
  • other specialists or expertise as needed.

Advice

BreastScreen Australia Clinical Advisory Committee advice

The BreastScreen Australia (BSA) Clinical Advisory Committee (CAC) provides advice to the BreastScreen Australia Program. Program managers have endorsed advice on the topics listed.

Last updated: 
19 January 2021